We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Plasmid-Based Culture Method for Massive Growth of Human Stem Cells

By LabMedica International staff writers
Posted on 04 Sep 2012
A recent paper described the use of plasmids rather than viral vectors to induce mature blood cells to revert to the primitive state of induced-pluripotent stem cells (iPS), which could then be used for the development of stem cell-based therapies.

Investigators at Johns Hopkins University (Baltimore, MD, USA) had already shown that adult blood cells could be transformed into iPS cells and then from iPS cells into functional heart cells. More...
In the current paper, which was published in the August 8, 2012, online edition of the journal PLoS One, they described a safer and more efficient method for inducing this transformation.

To avoid the possibility that a viral vector could introduce oncogenic genes along with the genes that cause reversion of the adult blood cells, the investigators used plasmids, rings of DNA that replicate briefly inside cells and then degrade. To further stimulate the reversion process the blood cells were cultured with elements from irradiated bone marrow along with other growth factors.

Previous methodology had yielded only a very small percentage of fully functional iPS cells. The technique described in the current study produced an unprecedented 50% to 60% functional iPS cells.

“Taking a cell from an adult and converting it all the way back to the way it was when that person was a six-day-old embryo creates a completely new biology toward our understanding of how cells age and what happens when things go wrong, as in cancer development,” said senior author Dr. Elias Zambidis, assistant professor of oncology and pediatrics at Johns Hopkins University.

Related Links:
Johns Hopkins University




Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
Automated Urinalysis Solution
UN-9000
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.